Position in HLN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$19,823,143
-$8,240,192 QoQ
Shares Held
2,124,667
-24.2% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $549,104,897 across 28 Drug Manufacturers - Specialty & Generic names. HLN ranks #12 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,360 | $59,091,431 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
1,667,073 | $57,797,420 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
106,561 | $57,737,945 | |
| 4 | ALKS |
Alkermes plc.
|
983,822 | $51,552,272 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
239,193 | $40,313,587 | |
| 6 | ZTS |
Zoetis Inc.
|
527,859 | $37,931,946 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
772,174 | $31,682,298 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,133,913 | $27,905,598 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,823,143 | 2,124,667 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $28,063,335 | 2,803,530 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $103,091 | 10,197 | Shares | Defined | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||